Insulin aspart, recombinant Subcutaneous and Polatuzumab Vedotin-piiq
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Polio vaccine, inactivated
- Insulin aspart, recombinant Subcutaneous-Poliovirus Vaccine (Inactivated)
- Insulin aspart, recombinant Subcutaneous-Poliovirus vaccine, inactivated Injection
- Insulin aspart, recombinant Subcutaneous-Polivy
- Insulin aspart, recombinant Subcutaneous-Polmon
- Insulin aspart, recombinant Subcutaneous-Polocaine
- Polatuzumab Vedotin-piiq-Insulin degludec
- Polatuzumab Vedotin-piiq-Insulin Degludec (U-100) Prefilled Pens
- Polatuzumab Vedotin-piiq-Insulin Degludec (U-100) Vials
- Polatuzumab Vedotin-piiq-Insulin Degludec (U-200) Prefilled Pens
- Polatuzumab Vedotin-piiq-Insulin degludec and liraglutide
- Polatuzumab Vedotin-piiq-Insulin degludec and liraglutide Subcutaneous